Search

Your search keyword '"Androgen suppression therapy -- Patient outcomes"' showing total 14 results
Start Over Descriptor "Androgen suppression therapy -- Patient outcomes" Topic risk factors
14 results on '"Androgen suppression therapy -- Patient outcomes"'

1. Researcher at Sapienza University of Rome Releases New Study Findings on Prostate Cancer (How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of Therapy)

Subjects
Care and treatment, Risk factors, Patient outcomes, Cancer recurrence -- Care and treatment -- Patient outcomes, Androgen suppression therapy -- Patient outcomes, Cancer research, Prostate cancer -- Care and treatment -- Patient outcomes, Cancer metastasis -- Risk factors, Combined modality therapy -- Patient outcomes, Oncology, Experimental, Metastasis -- Risk factors, Cancer -- Relapse -- Research
Abstract

2024 MAR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in prostate cancer. According to news reporting from [...]

Published
2024

2. Studies from University of Pennsylvania Describe New Findings in Prostate Cancer (Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance)

Subjects
Diagnosis, Care and treatment, Prevention, Analysis, Risk factors, Patient outcomes, Cancer recurrence -- Risk factors -- Prevention, Molecular mechanics -- Analysis, Androgen suppression therapy -- Patient outcomes, Prostatectomy -- Patient outcomes, Prostate cancer -- Diagnosis -- Care and treatment, Cancer -- Relapse
Abstract

2023 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on prostate cancer. According to news originating from [...]

Published
2023

3. Investigators at Fox Chase Cancer Center Discuss Findings in Prostate Cancer (Long-term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-sparing Intensity-modulated Radiation Therapy for Men With Clinically Localized ...)

Subjects
Care and treatment, Prevention, Complications and side effects, Risk factors, Patient outcomes, Intensity-modulated radiotherapy -- Patient outcomes, Impotence -- Risk factors -- Prevention, Androgen suppression therapy -- Patient outcomes, Prostate cancer -- Complications and side effects -- Care and treatment
Abstract

2023 JUL 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Oncology - Prostate Cancer are discussed in a new [...]

Published
2023

4. University Health Network Researcher Adds New Study Findings to Research in Prostate Cancer (Understanding treatment toxicity patterns through remote symptom monitoring and examining the effect of frailty in older men with metastatic prostate ...)

Subjects
Drug therapy, Testing, Prevention, Development and progression, Risk factors, Patient outcomes, Health aspects, Frail elderly -- Health aspects, Drug toxicity -- Testing, Androgen suppression therapy -- Patient outcomes, Prostate cancer -- Development and progression -- Drug therapy, Cancer metastasis -- Risk factors -- Prevention, Metastasis -- Risk factors -- Prevention, Drugs -- Health aspects
Abstract

2023 JUN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on prostate cancer have been published. According to news [...]

Published
2023

5. Research in the Area of Prostate Cancer Reported from Jinnah Postgraduate Medical Centre (Pluvicto - A novel treatment for Prostate Cancer)

Subjects
Care and treatment, Prevention, Analysis, Development and progression, Risk factors, Patient outcomes, Men's health -- Analysis, Prostate-specific antigen test -- Analysis, Androgen suppression therapy -- Patient outcomes, Prostate cancer -- Development and progression -- Care and treatment, Cancer metastasis -- Risk factors -- Prevention, Metastasis -- Risk factors -- Prevention, Men -- Health aspects, Immune system -- Testing
Abstract

2023 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in prostate cancer. According to news reporting out [...]

Published
2023

6. Report Summarizes Prostate Cancer Study Findings from Hannover Medical School (Using a Further Planning MRI after Neoadjuvant Androgen Deprivation Therapy Significantly Reduces the Radiation Exposure of Organs at Risk in External Beam ...)

Subjects
Planning, Care and treatment, Prevention, Complications and side effects, Risk factors, Patient outcomes, Company business planning, Androgen suppression therapy -- Patient outcomes, Radiotherapy -- Complications and side effects, Prostate cancer -- Care and treatment, Radiation exposure -- Risk factors -- Prevention, Magnetic resonance imaging -- Planning
Abstract

2023 FEB 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on prostate cancer is now available. According to news [...]

Published
2023

7. Researchers at Harvard Medical School Have Reported New Data on Androgens (Response To Supraphysiological Testosterone Is Predicted By a Distinct Androgen Receptor Cistrome)

Subjects
Diagnosis, Care and treatment, Measurement, Risk factors, Patient outcomes, Health aspects, Testosterone -- Measurement -- Health aspects, Androgen suppression therapy -- Patient outcomes, Prostate cancer -- Risk factors -- Diagnosis -- Care and treatment
Abstract

2022 JUL 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Drugs and Therapies - Androgens are discussed in a [...]

Published
2022

8. Reports from Henry Ford Hospital Highlight Recent Findings in Prostate Cancer (Anti-androgen Therapy Overcomes the Time Delay In Initiation of Salvage Radiation Therapy and Rescues the Oncological Outcomes In Men With Recurrent Prostate Cancer ...)

Subjects
Diagnosis, Care and treatment, Prevention, Risk factors, Patient outcomes, Androgen suppression therapy -- Patient outcomes, Prostatectomy -- Patient outcomes, Recurrence (Disease) -- Risk factors -- Prevention, Radiotherapy -- Patient outcomes, Prostate cancer -- Risk factors -- Diagnosis -- Care and treatment, Diseases -- Relapse
Abstract

2022 JUN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Oncology - Prostate Cancer are presented in a new [...]

Published
2022

9. New Prostate Cancer Study Findings Have Been Reported by Investigators at Council of Scientific and Industrial Research (CSIR) Indian Institute of Chemical Technology (Activation of Tgf-beta-smad2 Signaling By Il-6 Drives Neuroendocrine ...)

Subjects
Diagnosis, Care and treatment, Analysis, Risk factors, Patient outcomes, Interleukins -- Analysis, Androgen suppression therapy -- Patient outcomes, Transforming growth factors -- Analysis, Prostate cancer -- Risk factors -- Diagnosis -- Care and treatment
Abstract

2022 JUN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Oncology - Prostate Cancer. According to news [...]

Published
2022

10. Data on Prostate Cancer Detailed by Researchers at University of Chicago Medicine (Phase I/ii Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-resistant Prostate Cancer)

Subjects
Diagnosis, Care and treatment, Analysis, Risk factors, Patient outcomes, Dosage and administration, Androgen receptors -- Analysis, Mifepristone -- Dosage and administration, Enzalutamide -- Dosage and administration, Androgen suppression therapy -- Patient outcomes, Prostate cancer -- Risk factors -- Diagnosis -- Care and treatment, Transcription factors -- Analysis
Abstract

2022 JUN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Oncology - Prostate Cancer is the subject of a [...]

Published
2022

11. Hypothyroidism caused by apalutamide

Author

Daviduck, Quinn, North, Scott, and Swaleh, Rukia

Subjects
Diagnosis, Care and treatment, Prevention, Development and progression, Risk factors, Patient outcomes, Dosage and administration, Hypothyroidism -- Risk factors -- Prevention, Androgen suppression therapy -- Patient outcomes, Castration -- Patient outcomes, Prostate cancer -- Development and progression -- Care and treatment, Cancer metastasis -- Diagnosis -- Care and treatment, Apalutamide -- Dosage and administration, Metastasis -- Diagnosis -- Care and treatment
Abstract

1 Apalutamide is a common treatment for prostate cancer Apalutamide is an oral, nonsteroidal anti-androgen drug that delays disease progression and improves metastases-free and overall survival when added to androgen [...]

Published
2023
Full Text
View/download PDF

12. Researchers from Duke University Medical Center Describe Findings in Prostate Cancer [A Randomized Controlled Trial Comparing Changes In Fitness With or Without Supervised Exercise In Patients Initiated On Enzalutamide and Androgen Deprivation ...]

Subjects
Diagnosis, Care and treatment, Analysis, Risk factors, Patient outcomes, Dosage and administration, Androgen receptors -- Analysis, Enzalutamide -- Dosage and administration, Androgen suppression therapy -- Patient outcomes, Prostate cancer -- Risk factors -- Diagnosis -- Care and treatment
Abstract

2022 APR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Oncology - Prostate Cancer. According to news [...]

Published
2022

13. National Health Research Institutes Researchers Detail New Studies and Findings in the Area of Prostate Cancer (Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of ...)

Subjects
Diagnosis, Care and treatment, Measurement, Risk factors, Patient outcomes, Dosage and administration, Health aspects, Androgen suppression therapy -- Patient outcomes, Prostate specific antigen -- Measurement -- Health aspects, Prostate cancer -- Risk factors -- Diagnosis -- Care and treatment, Antineoplastic agents -- Dosage and administration
Abstract

2022 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on prostate cancer have been published. According to news [...]

Published
2022

14. Research from University Hospital Yields New Findings on Carcinomas (Intensity-Modulated Radiotherapy with Regional Hyperthermia for High-Risk Localized Prostate Carcinoma)

Subjects
Diagnosis, Care and treatment, Usage, Risk factors, Patient outcomes, Methods, Health aspects, Intensity-modulated radiotherapy -- Methods -- Patient outcomes, Hyperthermia treatment equipment -- Usage -- Health aspects, Androgen suppression therapy -- Patient outcomes, Prostate cancer -- Risk factors -- Diagnosis -- Care and treatment, Hyperthermia treatment systems (Medical care) -- Usage -- Health aspects
Abstract

2022 FEB 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on carcinomas. According to news reporting out of [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results